Your browser doesn't support javascript.
loading
Future perspectives in melanoma research "Melanoma Bridge", Napoli, November 30th-3rd December 2016.
Ascierto, Paolo A; Agarwala, Sanjiv S; Ciliberto, Gennaro; Demaria, Sandra; Dummer, Reinhard; Duong, Connie P M; Ferrone, Soldano; Formenti, Silvia C; Garbe, Claus; Halaban, Ruth; Khleif, Samir; Luke, Jason J; Mir, Lluis M; Overwijk, Willem W; Postow, Michael; Puzanov, Igor; Sondel, Paul; Taube, Janis M; Thor Straten, Per; Stroncek, David F; Wargo, Jennifer A; Zarour, Hassane; Thurin, Magdalena.
Afiliação
  • Ascierto PA; Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, IRCCS Istituto Nazionale Tumori "Fondazione G. Pascale", Naples, Italy. p.ascierto@istitutotumori.na.it.
  • Agarwala SS; Istituto Nazionale Tumori di Napoli Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. p.ascierto@istitutotumori.na.it.
  • Ciliberto G; Oncology & Hematology, St. Luke's University Hospital and Temple University, Bethlehem, PA, USA.
  • Demaria S; IRCCS "Regina Elena" National Cancer Institute, Rome, Italy.
  • Dummer R; Radiation Oncology and Pathology, Weill Cornell Medical College, New York City, NY, USA.
  • Duong CPM; Department of Dermatology, University of Zurich Hospital, Zurich, Switzerland.
  • Ferrone S; INSERM (National Institute of Health and Medical Research), Institut Gustave Roussy, Villejuif, France.
  • Formenti SC; Massachusetts General Hospital, Boston, MA, USA.
  • Garbe C; Department of Radiation Oncology, Weill Cornell Medical College, New York City, NY, USA.
  • Halaban R; Division of Dermatologic Oncology, Department of Dermatology, Eberhard Karls University, Tübingen, Germany.
  • Khleif S; Department of Dermatology, Yale University School of Medicine, New Haven, CT, USA.
  • Luke JJ; Georgia Cancer Center, Augusta University, Augusta, GA, USA.
  • Mir LM; Department of Hematology/Oncology, University of Chicago Comprehensive Cancer Center, Chicago, IL, USA.
  • Overwijk WW; CNRS (National Center for Scientific Research, France), University Paris-Saclay, Gustave Roussy, Villejuif, France.
  • Postow M; Division of Cancer Medicine, Department of Melanoma Medical Oncology-Research, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Puzanov I; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City, NY, USA.
  • Sondel P; Weill Cornell Medical College, New York, NY, USA.
  • Taube JM; Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA.
  • Thor Straten P; Pediatrics, Human Oncology and Genetics, University of Wisconsin, Madison, WI, USA.
  • Stroncek DF; UW Carbone Cancer Center, Madison, WI, USA.
  • Wargo JA; Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Zarour H; Center for Cancer Immune Therapy (CCIT), Department of Hematology, University Hospital Herlev, Herlev, Denmark.
  • Thurin M; Department of Immunology and Microbiology, University of Copenhagen, Herlev, Denmark.
J Transl Med ; 15(1): 236, 2017 11 16.
Article em En | MEDLINE | ID: mdl-29145885

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pesquisa Biomédica / Melanoma Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies Limite: Humans País/Região como assunto: Europa Idioma: En Revista: J Transl Med Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pesquisa Biomédica / Melanoma Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies Limite: Humans País/Região como assunto: Europa Idioma: En Revista: J Transl Med Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Itália